A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
Clinical trial NCT03381196 · TERMINATED
Trial details
- NCT number
- NCT03381196
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-21
- Primary completion
- 2020-05-28
- Enrollment
- 553
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.